Denosumab Protective Against Diabetes?

(MedPage Today) -- Continued treatment with the osteoporosis drug denosumab (Prolia) was tied to a lower risk of developing diabetes in a Taiwanese cohort study. In a propensity score-matched analysis, adherence to denosumab for osteoporosis was...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news